Mark Shlomchik, UPMC Endowed and distinguished professor in the University of Pittsburgh School of Medicine Department of Immunology, was elected as a 2024 Distinguished Fellow of the American Association of Immunologists (AAI). It is among the highest honors bestowed by the AAI.
Fellowship recognizes active, long-term members who have demonstrated excellence in research accomplishment in the field of immunology, exceptional leadership to the immunology community in academia at a national or international level, and notable distinction as an educator.
Shlomchik, who is also co-founder and was Chief Scientific Officer at Bluesphere Bio, a translational sciences company developing therapies that harness the immune response of patients to cure cancer, was chair of Pitt’s Department of Immunology from 2013-2022. He has made several fundamental contributions to understanding autoimmune diseases and immune responses, most recently in a Nature Immunology study that explains the developmental origins of memory B cells, which underly how vaccines and post-infection immunity are protective.
